| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/16/2011 | EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use. |
| 03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295433A2 JNK inhibitors |
| 03/16/2011 | EP2295418A1 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295409A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295080A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293812A1 Method for isolating cells and disease vectors from bodily fluids |
| 03/16/2011 | EP2293803A1 Immune system stimulating nutrition |
| 03/16/2011 | EP2293785A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 03/16/2011 | EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1641926B1 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1383785B1 Recombinant tumor specific antibody and use thereof |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/16/2011 | EP1298137B1 Novel substance having physiological activity, process for producing the same, and use |
| 03/16/2011 | CN1939324B Medical usage of periplocin A and E |
| 03/16/2011 | CN101986784A Engineered anti-TSLPR antibodies |
| 03/16/2011 | CN101986783A Anti-MDL-1 antibodies |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985432A 3-Fmoc amino-3-(3-nitro-4-fluophenyl) propionic acid and preparation method thereof |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101984966A New medicinal composition |
| 03/16/2011 | CN101664481B Health care product with effects of enhancing immunity and reducing lipid and preparation method thereof |
| 03/16/2011 | CN101590015B Cationic adhesion type mycophenolate mofetil nano eye drop |
| 03/16/2011 | CN101585804B Synthetic method of a fexofenadine hydrochloride |
| 03/16/2011 | CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/16/2011 | CN101475648B Preparation of Mallotus furetianus polysaccharide |
| 03/16/2011 | CN101306097B Zengkangning tablets quality control method |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906638 Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906483 Method for treating transplant rejection |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2675757C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 03/15/2011 | CA2608630C Polysaccharide extract of dendrobii herba and use thereof for treating autoimmune uveitis |
| 03/15/2011 | CA2597154C Use of iron(iii) complex compounds |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2477774C Indolylmaleimide derivatives |
| 03/15/2011 | CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 03/15/2011 | CA2468311C Benzothiazole derivatives |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/15/2011 | CA2163517C Surrogate tolerogenesis for the development of tolerance to xenografts |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028743A1 Pharmaceutical formulations for indibulin |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027875A1 Agent for improving intestinal tract barrier function |
| 03/10/2011 | WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | WO2010144874A3 Clusterin pharmaceuticals and treatment methods using the same |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059930 Composition for the Regulation of the Human Immune System and the Prevention and Treatment of Diseases Thereof |
| 03/10/2011 | US20110059919 Antiviral composition comprising a sulfated polysaccharide |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof |
| 03/10/2011 | US20110059190 Cistus extract containing enriched secondary plant ingredients |
| 03/10/2011 | US20110059163 Lyophilised antigen composition |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059137 Chemokine gene-modified cells for cancer immunotherapy |
| 03/10/2011 | US20110059133 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens |
| 03/10/2011 | US20110059130 Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods |
| 03/10/2011 | US20110059128 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 03/10/2011 | US20110059127 Use of mutant hiv-1 protease or siv protease as an adjuvant |
| 03/10/2011 | US20110059126 Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
| 03/10/2011 | US20110059125 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059119 Immunogen against campylobacter infection |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059109 Methods for inducing or enhancing an immune response by administering GITR-binding antibodies |
| 03/10/2011 | US20110059107 Antikine antibodies that bind to multiple cc chemokines |